Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
3.360
+0.270 (8.74%)
At close: Mar 13, 2026, 4:00 PM EDT
3.320
-0.040 (-1.19%)
After-hours: Mar 13, 2026, 7:59 PM EDT
Context Therapeutics Employees
Context Therapeutics had 12 employees as of September 30, 2025. The number of employees did not change since the number was reported on December 31, 2024.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,203,410
Market Cap
308.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | 7 | 140.00% |
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | 8 | 800.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| AC Immune | 172 |
| Cabaletta Bio | 151 |
| X4 Pharmaceuticals | 143 |
| Nautilus Biotechnology | 130 |
| Silence Therapeutics | 88 |
| Immuneering | 53 |
| NovaBridge Biosciences | 32 |
CNTX News
- 4 weeks ago - Context Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting - GlobeNewsWire
- 4 months ago - Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 4 months ago - Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer - GlobeNewsWire
- 5 months ago - Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting - GlobeNewsWire
- 5 months ago - Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 months ago - Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results - GlobeNewsWire